NYSE:HEXO - HEXO Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $1.95
  • Forecasted Upside: -70.25 %
  • Number of Analysts: 16
  • Breakdown:
  • 6 Sell Ratings
  • 7 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$6.54
▼ -0.46 (-6.57%)
1 month | 3 months | 12 months
Get New HEXO Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HEXO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HEXO

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$1.95
▼ -70.25% Downside Potential
This price target is based on 16 analysts offering 12 month price targets for HEXO in the last 3 months. The average price target is $1.95, with a high forecast of $8.00 and a low forecast of $0.75. The average price target represents a -70.25% upside from the last price of $6.54.
Hold
The current consensus among 16 polled investment analysts is to hold stock in HEXO. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 3 sell ratings
9/11/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 7 hold ratings
  • 4 sell ratings
12/10/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 6 sell ratings
3/9/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 7 sell ratings
6/7/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 8 hold ratings
  • 8 sell ratings
9/5/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 6 hold ratings
  • 7 sell ratings
12/4/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 6 sell ratings
2/2/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 6 sell ratings
3/4/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 7 hold ratings
  • 6 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/18/2021Canaccord GenuityBoost Price TargetBuy$5.00 ➝ $8.00High
i
2/17/2021CIBCUpgradeNeutral ➝ Sector OutperformLow
i
2/4/2021Stifel NicolausReiterated RatingSell$3.40Medium
i
1/26/2021Stifel NicolausReiterated RatingBuyHigh
i
12/16/2020Stifel NicolausUpgradeSell ➝ Hold$0.60 ➝ $1.40High
i
12/15/2020Canaccord GenuityBoost Price TargetHold$1.00 ➝ $1.25High
i
12/14/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector PerformHigh
i
Rating by D. Kideckel at Atb Cap Markets
11/2/2020Canaccord GenuityLower Price TargetHold$1.50 ➝ $1.00Medium
i
11/2/2020Stifel NicolausLower Price TargetSell$0.90 ➝ $0.60Medium
i
9/16/2020Jefferies Financial GroupReiterated RatingSell$0.75Medium
i
8/18/2020CIBCLower Price TargetUnderperform$1.00 ➝ $0.90Low
i
7/22/2020Cantor FitzgeraldUpgradeUnderweight ➝ Neutral$1.25High
i
Rating by P. Zuanic at Cantor Fitzgerald
7/1/2020Bryan, Garnier & CoDowngradeBuy ➝ SellMedium
i
6/29/2020BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$1.30Medium
i
Rating by Tamy Chen at BMO Capital Markets
6/12/2020MKM PartnersReiterated RatingHold$1.10Low
i
Rating by William Kirk at MKM Partners
6/12/2020Canaccord GenuityReiterated RatingHold$1.50Medium
i
6/11/2020OppenheimerReiterated RatingHoldHigh
i
6/1/2020Alliance Global PartnersReiterated RatingBuyHigh
i
Rating by A. Grey at Alliance Global Partners
4/15/2020Alliance Global PartnersLower Price TargetBuy$2.50 ➝ $1.50Low
i
3/31/2020MKM PartnersReiterated RatingHold$1.00High
i
Rating by William Kirk at MKM Partners
3/31/2020Bank of AmericaInitiated CoverageUnderperformHigh
i
3/31/2020Roth CapitalLower Price TargetNeutral$1.30 ➝ $1.00Medium
i
Rating by S. Fortune at Roth Capital
3/31/2020CitigroupInitiated CoverageUnderperform$1.00High
i
3/31/2020DesjardinsDowngradeBuy ➝ HoldHigh
i
3/18/2020AltaCorp CapitalDowngradeSector Perform ➝ Underperform$3.15 ➝ $1.20High
i
Rating by D. Kideckel at AltaCorp Capital
3/18/2020BMO Capital MarketsDowngradeMarket Perform ➝ UnderperformHigh
i
3/9/2020Stifel NicolausInitiated CoverageSell$1.15Medium
i
Rating by W. Andrew Carter at Stifel Nicolaus
3/2/2020Alliance Global PartnersInitiated CoverageBuyLow
i
2/21/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$1.00Low
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
1/28/2020MKM PartnersDowngradeBuy ➝ Neutral$1.50Medium
i
1/17/2020Roth CapitalLower Price TargetNeutral$2.25 ➝ $1.75Low
i
Rating by S. Fortune at Roth Capital
12/16/2019Pi FinancialDowngradeSell$2.00High
i
Rating by Devin Schilling at Pi Financial
12/13/2019Cantor FitzgeraldReiterated RatingSell$1.82High
i
Rating by Pablo Zuanic at Cantor Fitzgerald
11/5/2019Cantor FitzgeraldInitiated CoverageUnderweightLow
i
Rating by P. Zuanic at Cantor Fitzgerald
10/30/2019Eight CapitalDowngradeNeutral ➝ SellLow
i
10/30/2019Canaccord GenuityDowngradeBuy ➝ HoldLow
i
10/29/2019AltaCorp CapitalDowngradeOutperform ➝ Sector PerformHigh
i
Rating by D. Kideckel at AltaCorp Capital
10/29/2019Roth CapitalLower Price TargetNeutral$3.00 ➝ $2.50Low
i
Rating by S. Fortune at Roth Capital
10/25/2019CIBCDowngradeNeutral ➝ Sector Underperform$4.00 ➝ $3.00Low
i
Rating by John Zamparo at CIBC
10/21/2019CIBCReiterated RatingHold$4.00Medium
i
10/14/2019Seaport Global SecuritiesDowngradeBuy ➝ NeutralHigh
i
Rating by B. Hundley at Seaport Global Securities
10/11/2019Roth CapitalDowngradeBuy ➝ Neutral$3.00High
i
Rating by S. Fortune at Roth Capital
10/11/2019Jefferies Financial GroupUpgradeUnderperform ➝ HoldHigh
i
10/10/2019Beacon SecuritiesDowngradeBuy ➝ HoldHigh
i
Rating by R. Stanley at Beacon Securities
10/7/2019Bank of AmericaDowngradeBuy ➝ Underperform$9.00 ➝ $4.00Medium
i
Rating by Christopher Carey at Bank of America Co.
9/20/2019MKM PartnersInitiated CoverageBuy$12.00High
i
6/25/2019CIBCReiterated RatingOutperform ➝ Market PerformMedium
i
6/25/2019OppenheimerDowngradeOutperform ➝ Market PerformMedium
i
6/14/2019CIBCDowngradeSector Outperform ➝ NeutralLow
i
6/13/2019Bank of AmericaSet Price TargetBuy$10.00High
i
Rating by Christopher Carey at Bank of America Co.
4/25/2019DesjardinsInitiated CoverageBuy ➝ Buy$7.17High
i
Rating by J. Chu at Desjardins
4/17/2019Bank of AmericaInitiated CoverageBuy ➝ BuyHigh
i
4/4/2019AltaCorp CapitalReiterated RatingOutperformHigh
i
Rating by D. Kideckel at AltaCorp Capital
2/25/2019Jefferies Financial GroupInitiated CoverageUnderperform ➝ UnderperformLow
i
2/21/2019Seaport Global SecuritiesReiterated RatingBuyN/A
i
Rating by B. Hundley at Seaport Global Securities
2/21/2019Seaport Global SecuritiesInitiated CoverageBuy ➝ Buy$12.00High
i
Rating by B. Hundley at Seaport Global Securities
2/19/2019Beacon SecuritiesReiterated RatingBuyHigh
i
Rating by R. Stanley at Beacon Securities
2/19/2019OppenheimerInitiated CoverageOutperform$7.00High
i
2/19/2019CIBCInitiated CoverageOutperform ➝ Outperform$7.00High
i
(Data available from 3/4/2016 forward)
HEXO logo
HEXO Corp., through its subsidiaries, produces, markets, and sells cannabis in Canada. It offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. The company offers its adult-use and medical products under the HEXO brand name. Additionally, it offers cannabis beverages under the Little Victory, House of Terpenes, Mollo, Veryvell, and XMG brand; and cannabis products under Original Stash and Up brand names. The company was formerly known as The Hydropothecary Corporation and changes its name to HEXO Corp. in August 2018. HEXO Corp. was founded in 2013 and is headquartered in Kanata, Canada.
Read More

Today's Range

Now: $6.54
$6.25
$7.01

50 Day Range

MA: $7.34
$5.35
$10.28

52 Week Range

Now: $6.54
$1.38
$11.04

Volume

417,772 shs

Average Volume

9,163,887 shs

Market Capitalization

$798.95 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.41

Frequently Asked Questions

What sell-side analysts currently cover shares of HEXO?

The following sell-side analysts have issued reports on HEXO in the last twelve months: Alliance Global Partners, AltaCorp Capital, Atb Cap Markets, Bank of America Co., BMO Capital Markets, Bryan, Garnier & Co, Canaccord Genuity, Cantor Fitzgerald, CIBC, Citigroup Inc., Desjardins, Jefferies Financial Group Inc., MKM Partners, Oppenheimer Holdings Inc., Roth Capital, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for HEXO.

What is the current price target for HEXO?

11 Wall Street analysts have set twelve-month price targets for HEXO in the last year. Their average twelve-month price target is $1.95, suggesting a possible downside of 69.7%. Canaccord Genuity has the highest price target set, predicting HEXO will reach $8.00 in the next twelve months. Jefferies Financial Group Inc. has the lowest price target set, forecasting a price of $0.75 for HEXO in the next year.
View the latest price targets for HEXO.

What is the current consensus analyst rating for HEXO?

HEXO currently has 6 sell ratings, 7 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in HEXO, but not buy more shares or sell existing shares.
View the latest ratings for HEXO.

What other companies compete with HEXO?

How do I contact HEXO's investor relations team?

The company's listed phone number is 844-406-1852 and its investor relations email address is [email protected] The official website for HEXO is www.hexocorp.com.